FDA label
What is Doptelet used for?
Doptelet contains avatrombopag. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Doptelet lists 3 uses: Treatment of Thrombocytopenia in Patients with Chronic Liver Disease (CLD); Treatment of Thrombocytopenia in Adult Patients with Chronic Immune Thrombocytopenia (ITP); Treatment of Thrombocytopenia in Pediatric Patients 1 Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP).
Run it in Rivvi
Which 2027 plans near you dropped or restricted Doptelet?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Doptelet, tablet, film coated
Indications and Usage, quoted from the label by AkaRx, Inc. (NDA210238). Cross-references to other label sections are left out.
Treatment of Thrombocytopenia in Patients with Chronic Liver Disease (CLD)
DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
Treatment of Thrombocytopenia in Adult Patients with Chronic Immune Thrombocytopenia (ITP)
DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.
Treatment of Thrombocytopenia in Pediatric Patients 1 Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
DOPTELET is indicated for the treatment of thrombocytopenia in pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.
Source: DailyMed label, set id e2d5960d-6c18-46cc-86bd-089222b09852, version 21, effective August 13, 2025. NDC 71369-020, one of 1 listing for this product.
Questions
What is Doptelet used for?
The FDA label for Doptelet lists 3 uses: Treatment of Thrombocytopenia in Patients with Chronic Liver Disease (CLD); Treatment of Thrombocytopenia in Adult Patients with Chronic Immune Thrombocytopenia (ITP); Treatment of Thrombocytopenia in Pediatric Patients 1 Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP).
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.